{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:18:26Z","timestamp":1792660706726,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81374027"],"award-info":[{"award-number":["81374027"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773960"],"award-info":[{"award-number":["81773960"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>It has been testified that Diabetes mellitus (DM) has a close association with chronic inflammation and Toll-like Receptors (TLRs), and DM could be prevented by mulberry leaf. Therefore, a hypothesis came into being that mulberry leaf could ameliorate proinflammation and insulin resistance (IR) through TLRs and insulin signalling pathways.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Water extracts of mulberry leaf (WEM) was given to diabetic mice by gavage for 10\u2009weeks, and the diabetic mice was injected with low-dose streptozocin, fed with high-fat and high-sugar diet. Oral glucose tolerance tests (OGTTs) were conducted. At the same time, homeostasis model assessment of insulin (HOMA-IR) and the level of the inflammatory factor, tumour necrosis factor-\u03b1 (TNF-\u03b1) was measured. The expressions of critical nodes of TLRs and insulin signalling pathway were also examined.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>WEM contributed to a significant decrease in fasting blood glucose, AUC\u00a0from the investigation of OGTTs and HOMA-IR. The levels of the inflammatory factor, tumour necrosis factor-\u03b1 (TNF-\u03b1) also declined. Moreover, WEM suppressed the expression of TLR2, myeloid differentiation primary-response protein 88 (MyD88), tumour-necrosis-factor receptor-associated factor 6 (TRAF6), nuclear factor kappa B (NF-\u03baB) in the skeletal muscle. WEM could up-regulate the expression of insulin receptor (InsR) and insulin receptor substrate 1 (IRS1), and down-regulate the phosphorylation of IRS1 in adipose tissue.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Through this study, a conclusion could be made that WEM mitigates hyperglycemia, IR, and inflammation through the interactions among TLR2 signalling pathway, insulin signalling pathway and TNF-\u03b1.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12906-019-2742-y","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T16:03:17Z","timestamp":1574352197000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Mulberry leaf reduces inflammation and insulin resistance in type 2 diabetic mice by TLRs and insulin Signalling pathway"],"prefix":"10.1186","volume":"19","author":[{"given":"Simin","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baosheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,21]]},"reference":[{"key":"2742_CR1","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.tifs.2008.06.002","volume":"19","author":"MS Butt","year":"2008","unstructured":"Butt MS, Nazir A, Sultan MT, Schro\u00ebn K. Morus alba L. nature\u2019s functional tonic. Trends Food Sci Technol. 2008;19:505\u201312.","journal-title":"Trends Food Sci Technol"},{"key":"2742_CR2","unstructured":"Global report on diabetes. 2016. Available from: http:\/\/www.who.int"},{"key":"2742_CR3","first-page":"245","volume":"10","author":"LI Xin","year":"2012","unstructured":"Xin LI, Zeng GY, Tan JB, Feng XQ, Wang YJ. Active constituents of hypoglycemic part from Morus alba L. Cent South Pharm. 2012;10:245\u20138.","journal-title":"Cent South Pharm"},{"key":"2742_CR4","first-page":"3","volume":"3","author":"S Tian","year":"2016","unstructured":"Tian S, Tang M, Zhao B. Current anti-diabetes mechanisms and clinical trials using Morus alba L. J Tradit Chin Med Sci. 2016;3:3\u20138.","journal-title":"J Tradit Chin Med Sci"},{"key":"2742_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1042\/CS20110357","volume":"122","author":"MR Dasu","year":"2012","unstructured":"Dasu MR, Ramirez S, Isseroff RR. Toll-like receptors and diabetes: a therapeutic perspective. Clin Sci. 2012;122:203\u201314.","journal-title":"Clin Sci"},{"key":"2742_CR6","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2337\/dc09-1799","volume":"33","author":"MR Dasu","year":"2010","unstructured":"Dasu MR, Devaraj S, Park S, Jialal I. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care. 2010;33:861\u20138.","journal-title":"Diabetes Care"},{"key":"2742_CR7","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1172\/JCI25102","volume":"115","author":"KE Wellen","year":"2005","unstructured":"Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115:1111\u20139.","journal-title":"J Clin Invest"},{"key":"2742_CR8","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1210\/jc.2007-2185","volume":"93","author":"S Devaraj","year":"2008","unstructured":"Devaraj S, Dasu MR, Rockwood J, Winter W, Griffen SC, Jialal I. Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab. 2008;93:578\u201383.","journal-title":"J Clin Endocrinol Metab"},{"key":"2742_CR9","doi-asserted-by":"publisher","first-page":"5211","DOI":"10.4049\/jimmunol.1001388","volume":"187","author":"DH Kim","year":"2011","unstructured":"Kim DH, Lee JC, Kim S, Oh SH, Lee MK, Kim KW, Lee MS. Inhibition of autoimmune diabetes by TLR2 tolerance. J Immunol. 2011;187:5211\u201320.","journal-title":"J Immunol"},{"key":"2742_CR10","first-page":"263","volume":"18","author":"B Zhao","year":"2012","unstructured":"Zhao B, Gao X, Liu Y, Zhu Y, Xu T. Effect and mechanism of Morus alba for treating non-insulin-dependent diabetes mellitus. Chin J Exp Tradit Med Formulae. 2012;18:263\u20136.","journal-title":"Chin J Exp Tradit Med Formulae"},{"key":"2742_CR11","first-page":"25","volume":"22","author":"M Tang","year":"2016","unstructured":"Tang M, Tian H, Yang W, Hou C, Tian S, Wang H, Qu M, Shi R. Identification of constituents in Mori folium aqueous extract and drug serum. Chin J Exp Tradit Med Formulae. 2016;22:25\u20139.","journal-title":"Chin J Exp Tradit Med Formulae"},{"key":"2742_CR12","first-page":"137","volume":"23","author":"S Tian","year":"2017","unstructured":"Tian S, Liu C, Ma S, Zhang C, Zhao B. Effect of Mori folium on gene expression of tlrs in liver of diabetic mice. Chin J Exp Tradit Med Formulae. 2017;23:137\u201342.","journal-title":"Chin J Exp Tradit Med Formulae"},{"key":"2742_CR13","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00011-017-1030-x","volume":"66","author":"P Soma","year":"2017","unstructured":"Soma P, Swanepoel AC, Bester J, Pretorius E. Tissue factor levels in type 2 diabetes mellitus. Inflamm Res. 2017;66:365\u20138.","journal-title":"Inflamm Res"},{"key":"2742_CR14","doi-asserted-by":"publisher","first-page":"e0133212","DOI":"10.1371\/journal.pone.0133212","volume":"10","author":"L Pan","year":"2015","unstructured":"Pan L, Weng H, Li H, Liu Z, Xu Y, Zhou C, Lu X, Su X, Zhang Y, Chen D. Therapeutic effects of Bupleurum polysaccharides in Streptozotocin induced diabetic mice. PLoS One. 2015;10:e0133212.","journal-title":"PLoS One"},{"key":"2742_CR15","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1210\/jc.2002-021127","volume":"88","author":"S Soonthornpun","year":"2003","unstructured":"Soonthornpun S, Setasuban W, Thamprasit A, Chayanunnukul W, Rattarasarn C, Geater A. Novel insulin sensitivity index derived from oral glucose tolerance test. J Clin Endocrinol Metab. 2003;88:1019\u201323.","journal-title":"J Clin Endocrinol Metab"},{"key":"2742_CR16","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1126\/science.aaf1064","volume":"351","author":"JG O'Rourke","year":"2016","unstructured":"O'Rourke JG, Bogdanik L, Y\u00e1\u00f1ez A, Lall D, Wolf AJ, Muhammad AK, et al. C9orf72 is required for proper macrophage and microglial function in mice. Science. 2016;351:1324\u20139.","journal-title":"Science"},{"key":"2742_CR17","doi-asserted-by":"publisher","first-page":"778","DOI":"10.2337\/diabetes.54.3.778","volume":"54","author":"X Liu","year":"2005","unstructured":"Liu X, Wei J, Peng DH, Layne MD, Yet SF. Absence of heme oxygenase-1 exacerbates myocardial ischemia\/reperfusion injury in diabetic mice. Diabetes. 2005;54:778\u201384.","journal-title":"Diabetes"},{"key":"2742_CR18","first-page":"791","volume":"40","author":"B Andallu","year":"2002","unstructured":"Andallu B, Nch V. Control of hyperglycemia and retardation of cataract by mulberry ( Morus indica L. ) leaves in streptozotocin diabetic rats. Indian J Exp Biol. 2002;40:791\u20135.","journal-title":"Indian J Exp Biol"},{"key":"2742_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4103\/0253-7613.40483","volume":"40","author":"J Mohammadi","year":"2008","unstructured":"Mohammadi J, Naik PR. Evaluation of hypoglycemic effect of Morus alba in an animal model. Indian J Pharm. 2008;40:15\u20138.","journal-title":"Indian J Pharm"},{"key":"2742_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/01.NAJ.0000415961.92674.d4","volume":"112","author":"L Shane-Mcwhorter","year":"2012","unstructured":"Shane-Mcwhorter L. Dietary supplements and probiotics for diabetes. Am J Nurs. 2012;112:47\u201353.","journal-title":"Am J Nurs"},{"key":"2742_CR21","first-page":"824","volume":"49","author":"S Yang","year":"2014","unstructured":"Yang S, Wang BL, Li Y. Advances in the pharmacological study of Morus alba L. Yao Xue Xue Bao. 2014;49:824\u201331.","journal-title":"Yao Xue Xue Bao"},{"key":"2742_CR22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2337\/diabetes.53.suppl_3.S215","volume":"53","author":"MS Winzell","year":"2004","unstructured":"Winzell MS, Ahr\u00e9n B. The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes. 2004;53:215\u20139.","journal-title":"Diabetes"},{"key":"2742_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12933-016-0485-3","volume":"16","author":"A Grossman","year":"2017","unstructured":"Grossman A, Grossman E. Blood pressure control in type 2 diabetic patients. Cardiovasc Diabetol. 2017;16:3.","journal-title":"Cardiovasc Diabetol"},{"key":"2742_CR24","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.ijbiomac.2014.09.060","volume":"72","author":"C Ren","year":"2015","unstructured":"Ren C, Zhang Y, Cui W, Lu G, Wang Y. A polysaccharide extract of mulberry leaf ameliorates hepatic glucosemetabolism and insulin signaling in rats with type 2 diabetes inducedby high fat-diet and streptozotocin. Int J Biol Macromol. 2015;72:951\u20139.","journal-title":"Int J Biol Macromol"},{"key":"2742_CR25","doi-asserted-by":"publisher","first-page":"E1323","DOI":"10.1152\/ajpendo.90617.2008","volume":"295","author":"S Andrikopoulos","year":"2008","unstructured":"Andrikopoulos S, Blair AR, Deluca N, Fam BC, Proietto J. Evaluating the glucose tolerance test in mice. Am J Physiol Endocrinol Metab. 2008;295:E1323\u201332.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2742_CR26","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nrd2070","volume":"5","author":"LA O'Neill","year":"2006","unstructured":"O'Neill LA. Targeting signal transduction as a strategy to treat inflammatory diseases. Nat Rev Drug Discov. 2006;5:549\u201363.","journal-title":"Nat Rev Drug Discov"},{"key":"2742_CR27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrd3203","volume":"9","author":"EJ Hennessy","year":"2010","unstructured":"Hennessy EJ, Parker AE, O'Neill LA. Targeting toll-like receptors: emerging therapeutics? Nat Rev Drug Discov. 2010;9:293\u2013307.","journal-title":"Nat Rev Drug Discov"},{"key":"2742_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1196\/annals.1447.063","volume":"1150","author":"FS Wong","year":"2008","unstructured":"Wong FS, Wen L. Toll-like receptors and diabetes. Ann N Y Acad Sci. 2008;1150:123\u201332.","journal-title":"Ann N Y Acad Sci"},{"key":"2742_CR29","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1093\/intimm\/dxl045","volume":"18","author":"MK Mohammad","year":"2006","unstructured":"Mohammad MK, Morran M, Slotterbeck B, Leaman DW, Sun Y, Hv G, et al. Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse. Int Immunol. 2006;18:1101\u201313.","journal-title":"Int Immunol"},{"key":"2742_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s11658-016-0002-4","volume":"28","author":"Z Sepehri","year":"2016","unstructured":"Sepehri Z, Kiani Z, Nasiri AA, Kohan F. Toll-like receptor 2 and type 2 diabetes. Cell Mol Biol Lett. 2016;28:2.","journal-title":"Cell Mol Biol Lett"},{"key":"2742_CR31","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.immuni.2007.06.010","volume":"27","author":"HS Kim","year":"2007","unstructured":"Kim HS, Han MS, Chung KW, Kim S, Kim E, Kim MJ, et al. Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes. Immunity. 2007;27:321\u201333.","journal-title":"Immunity"},{"key":"2742_CR32","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.2337\/db08-0564","volume":"57","author":"MR Dasu","year":"2008","unstructured":"Dasu MR, Devaraj S, Zhao L, Hwang DH, Jialal I. High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes. 2008;57:3090\u20138.","journal-title":"Diabetes"},{"key":"2742_CR33","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nri1391","volume":"4","author":"S Akira","year":"2004","unstructured":"Akira S, Takeda K. Toll-like receptor signaling. Nat Rev Immunol. 2004;4:499\u2013511.","journal-title":"Nat Rev Immunol"},{"key":"2742_CR34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1172\/JCI10582","volume":"106","author":"JE Pessin","year":"2000","unstructured":"Pessin JE, Saltiel AR. Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest. 2000;106:165\u20139.","journal-title":"J Clin Invest"},{"key":"2742_CR35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nrm1837","volume":"7","author":"CM Taniguchi","year":"2006","unstructured":"Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol. 2006;7:85\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2742_CR36","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1097-2765(00)80155-0","volume":"2","author":"JC Br\u00fcning","year":"1998","unstructured":"Br\u00fcning JC, Michael MD, Winnay JN, Hayashi T, H\u00f6rsch D, Accili D, et al. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell. 1998;2:559\u201369.","journal-title":"Mol Cell"},{"issue":"suppl","key":"2742_CR37","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s001250051387","volume":"40","author":"MF White","year":"1997","unstructured":"White MF. The insulin signalling system and the IRS proteins. Diabetologia. 1997;40(suppl):2\u201317.","journal-title":"Diabetologia"},{"key":"2742_CR38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nm1166","volume":"11","author":"D Cai","year":"2005","unstructured":"Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med. 2005;11:183\u201390.","journal-title":"Nat Med"},{"key":"2742_CR39","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1097-2765(05)00010-9","volume":"6","author":"I Shimomura","year":"2000","unstructured":"Shimomura I, Matsuda M, Hammer RE, Bashmakov Y, Brown MS, Goldstein JL. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and Ob\/Ob mice. Mol Cell. 2000;6:77\u201386.","journal-title":"Mol Cell"},{"key":"2742_CR40","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.2337\/diab.46.9.1526","volume":"46","author":"J Ventre","year":"1997","unstructured":"Ventre J, Doebber T, Wu M, MacNaul K, Stevens K, Pasparakis M, et al. Targeted disruption of the tumor necrosis factor-alpha gene: metabolic consequences in obese and nonobese mice. Diabetes. 1997;46:1526\u201331.","journal-title":"Diabetes"},{"key":"2742_CR41","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s11908-012-0273-5","volume":"14","author":"JH Boyd","year":"2012","unstructured":"Boyd JH. Toll-like receptors and opportunities for new sepsis therapeutics. Curr Infect Dis Rep. 2012;14:455\u201361.","journal-title":"Curr Infect Dis Rep"},{"key":"2742_CR42","doi-asserted-by":"publisher","first-page":"7461","DOI":"10.4049\/jimmunol.0901517","volume":"183","author":"M Jagannathan","year":"2009","unstructured":"Jagannathan M, Hasturk H, Liang Y, Shin H, Hetzel JT, Kantarci A, et al. TLR cross-talk specifically regulates cytokine production by B cells from chronic inflammatory disease patients. J Immunol. 2009;183:7461\u201370.","journal-title":"J Immunol"},{"key":"2742_CR43","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/2049-632X.12154","volume":"71","author":"LV Stamm","year":"2014","unstructured":"Stamm LV, Drapp RL. TLR2 and TLR4 mediate the TNF\u03b1 response to Vibrio vulnificus biotype 1. Pathog Dis. 2014;71:357\u201361.","journal-title":"Pathog Dis"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-019-2742-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12906-019-2742-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-019-2742-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:54:18Z","timestamp":1605833658000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-019-2742-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,21]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2742"],"URL":"https:\/\/doi.org\/10.1186\/s12906-019-2742-y","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,21]]},"assertion":[{"value":"12 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal procedures were approved and conducted according to the guidelines of the Laboratory Animal Care Committee of Beijing University of Chinese Medicine, China (the approved number: BUCM-4-2015072201-3002).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"326"}}